T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Ally Financial
ALLY
$13.6B
| $24.7M | ﹤0.01% |
608,179
+432,350
| +246% | +$15.8M |
|
927
Cogent Communications
CCOI
$530M
| $24.3M | ﹤0.01% |
371,773
-289
| -0.1% | -$21.1K |
|
928
W.R. Berkley
WRB
$26.2B
| $24.2M | ﹤0.01% |
411,168
+6,436
| +2% | +$348K |
|
929
Advanced Drainage Systems
WMS
$11.3B
| $24.1M | ﹤0.01% |
139,677
+19,626
| +16% | +$2.95M |
|
930
Seagate
STX
$209B
| $24M | ﹤0.01% |
258,033
+6,044
| +2% | +$532K |
|
931
BHP
BHP
$222B
| $24M | ﹤0.01% |
415,309
-3,227
| -0.8% | -$193K |
|
932
Photronics
PLAB
$1.97B
| $23.8M | ﹤0.01% |
840,538
+582,664
| +226% | +$17.3M |
|
933
Enovis
ENOV
$1.48B
| $23.8M | ﹤0.01% |
381,118
+179,276
| +89% | +$10.7M |
|
934
MP Materials
MP
$9.91B
| $23.8M | ﹤0.01% |
1,661,887
+1,598,861
| +2,537% | +$25.3M |
|
935
Expeditors International
EXPD
$24.3B
| $23.7M | ﹤0.01% |
195,172
+2,724
| +1% | +$337K |
|
936
Protagonist Therapeutics
PTGX
$9.8B
| $23.7M | ﹤0.01% |
819,296
-4,444
| -0.5% | -$121K |
|
937
FormFactor
FORM
$10.3B
| $23.5M | ﹤0.01% |
515,877
+2,623
| +0.5% | +$109K |
|
938
Evolent Health
EVH
$527M
| $23.5M | ﹤0.01% |
717,334
+75,376
| +12% | +$2.41M |
|
939
Citizens Financial Group
CFG
$31.2B
| $23.3M | ﹤0.01% |
641,573
-2,885
| -0.4% | -$94.6K |
|
940
Payoneer
PAYO
$2.42B
| $23.3M | ﹤0.01% |
4,790,400
+178,842
| +4% | +$871K |
|
941
Globe Life
GL
$14B
| $23.2M | ﹤0.01% |
198,945
+9,497
| +5% | +$1.16M |
|
|
MRO
942
DELISTED
Marathon Oil Corporation
MRO
| $23.1M | ﹤0.01% |
815,085
+23,323
| +3% | +$563K |
|
943
Celanese
CE
$4.86B
| $23.1M | ﹤0.01% |
134,378
+1,367
| +1% | +$208K |
|
944
Kyverna Therapeutics
KYTX
$500M
| $23.1M | ﹤0.01% |
+929,634
| New | +$25.9M |
|
945
Elastic
ESTC
$8.94B
| $23M | ﹤0.01% |
229,342
-30,234
| -12% | -$3.48M |
|
946
Red Rock Resorts
RRR
$3.67B
| $22.6M | ﹤0.01% |
378,193
-365
| -0.1% | -$20.2K |
|
947
Herc Holdings
HRI
$5.64B
| $22.6M | ﹤0.01% |
134,339
-13,938
| -9% | -$2.12M |
|
948
ACI Worldwide
ACIW
$5.42B
| $22.4M | ﹤0.01% |
673,142
+3,983
| +0.6% | +$123K |
|
949
Carnival Corporation Ltd
CCL
$38.9B
| $22.3M | ﹤0.01% |
1,366,661
+20,724
| +2% | +$337K |
|
950
Quaker Houghton
KWR
$2.95B
| $22.2M | ﹤0.01% |
108,122
+3,441
| +3% | +$682K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.